Artelo Biosciences, Inc. (ARTL)

NASDAQ: ARTL · Real-Time Price · USD

6.04

-0.18 (-2.89%)

At close: Sep 4, 2026, 4:00 PM EDT

6.20

+0.16 (2.65%)

After-hours: Sep 4, 2026, 7:14 PM EDT

Artelo Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	4.2	0.6	2.34	2.82	6.89	12.16
Short-Term Investments	-	-	-	-	1.5	-
Trading Asset Securities	-	-	-	7.61	9.15	11.95
Cash & Short-Term Investments	4.2	0.6	2.34	10.43	17.53	24.11
Cash Growth	103.19%	-74.34%	-77.58%	-40.53%	-27.29%	139.57%
Prepaid Expenses	0.17	0.1	0.22	0.55	0.79	0.5
Total Current Assets	4.37	0.7	2.56	10.98	18.32	24.61
Property, Plant & Equipment	0.05	0.06	0.1	0.02	0.06	0.08
Long-Term Investments	-	-	-	-	-	1.52
Other Intangible Assets	2.04	2.04	2.04	2.04	2.04	2.04
Other Long-Term Assets	0	0	0	0	0	0
Total Assets	6.46	2.8	4.7	13.04	20.42	28.25

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	1.3	3.04	1.68	1.24	0.91	0.98
Accrued Expenses	0.11	0.36	0.06	0.03	0.05	0.02
Short-Term Debt	-	0.61	-	-	-	-
Current Portion of Leases	0.04	0.04	0.04	0.02	0.04	0.03
Other Current Liabilities	-	0	-	-	-	-
Total Current Liabilities	1.46	4.04	1.77	1.29	1	1.03
Long-Term Leases	0.01	0.03	0.07	-	0.02	0.06
Total Liabilities	1.46	4.07	1.84	1.29	1.02	1.08

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	73.64	62.01	53.19	52.26	50.68	48.12
Retained Earnings	-68.4	-63.02	-50.14	-40.31	-31.02	-20.94
Comprehensive Income & Other	-0.24	-0.27	-0.2	-0.2	-0.25	-0.02
Shareholders' Equity	5	-1.27	2.86	11.75	19.4	27.17
Total Liabilities & Equity	6.46	2.8	4.7	13.04	20.42	28.25

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	0.05	0.68	0.1	0.02	0.06	0.09
Net Cash (Debt)	4.15	-0.08	2.23	10.4	17.47	24.03
Net Cash Growth	249.24%	-	-78.53%	-40.45%	-27.28%	140.97%
Net Cash Per Share	33.53	-2.05	112.32	569.34	998.97	1745.37
Filing Date Shares Outstanding	0.51	0.08	0.02	0.02	0.02	0.02
Total Common Shares Outstanding	0.47	0.07	0.02	0.02	0.02	0.02
Working Capital	2.92	-3.35	0.79	9.69	17.32	23.58
Book Value Per Share	10.74	-17.01	141.07	597.00	1100.69	1560.60
Tangible Book Value	2.96	-3.31	0.82	9.71	17.36	25.13
Tangible Book Value Per Share	6.36	-44.28	40.39	493.42	985.02	1443.47

SEC Filings: 10-K · 10-Q